BRVE — Braveheart Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2131524 ·
Last close
$27.03
Market Cap
—
52W High
$32.00
52W Low
$24.88
ADV30
991,017
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -15,049,000 | -14,280,000 | 81,878,000 | 80,576,000 | 160,270,000 |
| Mar 2025 | 0 | — | -5,000 | -99,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,186,000
Investing CF
$-3,036,000
Financing CF
$-363,000
CapEx
$-3,036,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-05
Balance + Analyst (yfinance extras)
Retained Earnings
$-80,332,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-15,054,000
Pretax Income TTM
$-14,379,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 1y)
Revenues vs Net Income (last 1y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -4,505,000 | -66,052,000 | 89,350,000 | 155,222,000 | — | -2,014,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.05T | $1180.16 | — |
| JNJ | JOHNSON & JOHNSON | $627.42B | $260.35 | — |
| ABBV | AbbVie Inc. | $440.83B | $249.46 | — |
| MRK | Merck & Co., Inc. | $335.14B | $135.84 | — |
| NVSEF | NOVARTIS AG | $300.12B | $157.90 | — |
Recent Insider Activity
No insider activity indexed for this ticker.